Literature DB >> 10203148

Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.

G Kouraklis1, T J Triche, R Wesley, M Tsokos.   

Abstract

Accumulated clinical evidence suggests that alveolar rhabdomyosarcoma (ARMS) is more aggressive than embryonal rhabdomyosarcoma (ERMS). Here, we study six childhood rhabdomyosarcoma cell lines, three ERMS and three ARMS. We have assayed the ability of the tumor cells to grow in culture and in nude mice as well as their propensity for pulmonary metastasis formation by tail vein injection. We also compared levels of c- and N-myc oncogene expression and DNA copy number. We find no correlation of histologic tumor type (i.e. ERMS versus ARMS) with growth rate in culture, but we do find suggestive correlations of histologic type with tumorigenicity (mean tumor diameter in millimeters at 6 wk: ARMS 30, ERMS 10; p1 = 0.1) and metastasis formation (ARMS 12, ERMS 0; p1 = 0.1). These properties also correlate with uniform greater overexpression of c-myc in ARMS (mean 39.3-fold, range 16-83) compared with ERMS (mean 5.3, range 4-8) (p1 = 0.05, control fibroblasts = 1). Although c-myc was often amplified in vitro (four of six lines), there was no correlation with histologic type (2/3 ARMS, 2/3 ERMS). These data on rhabdomyosarcoma cell lines derived from verified ERMS and ARMS tumors support the impression from previous clinicopathologic observations that ARMS is a more malignant form of rhabdomyosarcoma than ERMS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203148     DOI: 10.1203/00006450-199904010-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

1.  The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma.

Authors:  Hemant K Bid; Doris A Phelps; Linlin Xaio; Denis C Guttridge; Jiayuh Lin; Cheryl London; Laurence H Baker; Xiaokui Mo; Peter J Houghton
Journal:  Mol Cancer Ther       Date:  2016-02-23       Impact factor: 6.261

2.  An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.

Authors:  W J Fredericks; K Ayyanathan; M Herlyn; J R Friedman; F J Rauscher
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

3.  Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.

Authors:  Charles Keller; Benjamin R Arenkiel; Cheryl M Coffin; Nabeel El-Bardeesy; Ronald A DePinho; Mario R Capecchi
Journal:  Genes Dev       Date:  2004-10-15       Impact factor: 11.361

4.  Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosarcoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Svetlana Tafjord; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

5.  Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.

Authors:  Alan C Taylor; Katja Schuster; Pamela P McKenzie; Linda C Harris
Journal:  Mol Cancer       Date:  2006-11-02       Impact factor: 27.401

6.  Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.

Authors:  L Tombolan; E Poli; P Martini; A Zin; C Millino; B Pacchioni; B Celegato; G Bisogno; C Romualdi; A Rosolen; G Lanfranchi
Journal:  BMC Cancer       Date:  2016-11-14       Impact factor: 4.430

7.  NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.

Authors:  Lucia Tombolan; Elena Poli; Paolo Martini; Angelica Zin; Chiara Romualdi; Gianni Bisogno; Gerolamo Lanfranchi
Journal:  Oncotarget       Date:  2017-05-16

8.  Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events.

Authors:  Tara E Crawford Parks; Kristen A Marcellus; Jonathan Langill; Aymeric Ravel-Chapuis; Jean Michaud; Kyle N Cowan; Jocelyn Côté; Bernard J Jasmin
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

9.  MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA.

Authors:  Lucia Tombolan; Matteo Zampini; Silvia Casara; Elena Boldrin; Angelica Zin; Gianni Bisogno; Angelo Rosolen; Cristiano De Pittà; Gerolamo Lanfranchi
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

10.  The c-Myc/AKT1/TBX3 Axis Is Important to Target in the Treatment of Embryonal Rhabdomyosarcoma.

Authors:  Danica Sims; Hapiloe Mabaruti Maranyane; Victoria Damerell; Dhirendra Govender; Ashwin W Isaacs; Jade Peres; Sharon Prince
Journal:  Cancers (Basel)       Date:  2020-02-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.